UnknownNot Applicable

SMS Reminders and Treatment Compliance and Efficacy in Patients With FGIDs

China176 participantsStarted 2019-04-30

Plain-language summary

The effect of SMS follow-up on drug compliance and efficacy in patients with FGIDs has not been reported in the literature. We, therefore, conducted a prospective randomized controlled trial to investigate whether SMS follow-up could improve treatment adherence in patients with FGIDs, which in turn would help symptom relief and improve treatment outcomes.

Who can participate

Age range18 Years – 70 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients with newly diagnosed FGIDs according to Rome-IV * Aged 18-70 years * With no obvious organic abnormalities Exclusion Criteria: * With organic gastrointestinal diseases * With psychiatric diseases or are taking psychotropic agents * With severe cardiopulmonary or other organ diseases * Pregnant women

What they're measuring

Treatment compliance in outpatients with FGIDs

Timeframe: week2

Trial details

NCT IDNCT04052750

SponsorRenJi Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2020-04-30

View on ClinicalTrials.gov More Functional Gastrointestinal Disorders trials